Cryptococcosis
Mostrando 13-24 de 268 artigos, teses e dissertações.
-
13. Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome
Cryptococcosis diagnosis has been recently improved by the use of rapid cryptococcal antigen testing with lateral flow assays, which have proved sensitive and specific. Using “test and treat” screening strategies for cryptococcal disease with these tests has been showed effective in reducing cryptococcal meningitis (CM) in HIV-infected patients. Recommen
Mem. Inst. Oswaldo Cruz. Publicado em: 07/05/2018
-
14. Variability in innate host immune responses to cryptococcosis
Cryptococcosis is an invasive fungal disease caused by Cryptococcus neoformans and the closely related species C. gattii. The severe form of the disease, cryptococcal meningitis (CM), is rapidly fatal without treatment. Although typically a disease of immunocompromised (especially HIV-positive) individuals, there is growing awareness of cryptococcal disease
Mem. Inst. Oswaldo Cruz. Publicado em: 16/04/2018
-
15. Neglected disease, neglected populations: the fight against Cryptococcus and cryptococcosis
Mem. Inst. Oswaldo Cruz. Publicado em: 16/04/2018
-
16. The status of cryptococcosis in Latin America
Cryptococcosis is a life-threatening fungal infection caused by the encapsulated yeasts Cryptococcus neoformans and C. gattii, acquired from the environment. In Latin America, as occurring worldwide, C. neoformans causes more than 90% of the cases of cryptococcosis, affecting predominantly patients with HIV, while C. gattii generally affects otherwise health
Mem. Inst. Oswaldo Cruz. Publicado em: 05/04/2018
-
17. The war on cryptococcosis: A Review of the antifungal arsenal
Cryptococcal meningitis is the most common central nervous system infection in the world today. It occurs primarily, but not exclusively, in immunocompromised individuals and despite substantial improvement in management of clinical events like AIDS, the numbers of cases of cryptococcosis remain very high. Unfortunately, despite several antifungal agents ava
Mem. Inst. Oswaldo Cruz. Publicado em: 19/02/2018
-
18. Fluconazole levels in serum and cerebrospinal fluid according to daily dosage in patients with cryptococcosis and other fungal infections
ABSTRACT Fluconazole is extensively used for the treatment of candidiasis and cryptococcosis. Among other factors, successful treatment is related to appropriate fluconazole levels in blood and cerebrospinal fluid. In the present study, fluconazole levels were determined in 15 patients, 14 of whom had AIDS and 13 had neurocryptococcosis. The only selection c
Braz J Infect Dis. Publicado em: 2018-01
-
19. Evaluation of a Cryptococcal antigen Lateral Flow Assay in serum and cerebrospinal fluid for rapid diagnosis of cryptococcosis in Colombia
ABSTRACT A Lateral Flow Assay to detect cryptococcal antigen (CrAg® LFA) in serum and cerebrospinal fluid for the rapid diagnosis of cryptococcosis was evaluated. A retrospective validation was performed. Sensitivity and specificity of the CrAg® LFA was 100%. High concordance (kappa index=1.0) between Cryptococcal Antigen Latex Agglutination System (CALAS�
Rev. Inst. Med. trop. S. Paulo. Publicado em: 21/12/2017
-
20. Cryptococcosis in a transplanted kidney allograft
Rev. Soc. Bras. Med. Trop.. Publicado em: 2017-12
-
21. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease
ABSTRACT One of the factors causing treatment failure in cryptococcosis is the resistance of Cryptococcus spp. to antifungal drugs, which has motivated the susceptibility assessment of isolates from patients with cryptococcosis, different clinical conditions and infections outcomes. Clinical isolates of Cryptococcus spp. from three different groups of patien
Rev. Inst. Med. trop. S. Paulo. Publicado em: 03/08/2017
-
22. Fatal Cryptococcus gattii genotype VGI infection in an HIV-positive patient in Barranquilla, Colombia
ABSTRACT Cryptococcosis is a major invasive fungal disease related worldwide with the AIDS population. New reports of HIV/AIDS cases to the national public health surveillance system (SIVIGILA) in Colombia have shown that there is a growing community at risk of contracting cryptococcosis throughout the country who do not have access to ART. Even though the m
Rev. Inst. Med. trop. S. Paulo. Publicado em: 01/06/2017
-
23. The epidemiology of cryptococcosis and the characterization of Cryptococcus neoformans isolated in a Brazilian University Hospital
ABSTRACT Cryptococcosis, a systemic disease caused by the fungus Cryptococcus neoformans/ Cryptococcus gattii is more severe in immunocompromised individuals. This study aimed to analyze the epidemiology of the disease, the molecular characteristics and the antifungal susceptibility of C. neoformans isolated from patients treated in a Brazilian university ho
Rev. Inst. Med. trop. S. Paulo. Publicado em: 13/04/2017
-
24. Disseminated cryptococcosis with skin lesions: report of a case series
Abstract Cryptococcosis is a common fungal infection in immunocompromised patients, caused by genus Cryptococcus, presenting with meningitis, pneumonia, and skin lesions. Cutaneous presentation can be varied, but specifically in solid organ transplant recipients (iatrogenically immunocompromised), cryptococcosis should always be considered in the differentia
An. Bras. Dermatol.. Publicado em: 2017